Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-59.23	63.16	154.90
Graham Fair Price	27.96	9.35	7.31
PEG	9469.17	0.11	< 0.005
Price/Book	-13.70	3.19	3.69
Price/Cash Flow	149.56	-361.60	144.89
Prices/Earnings	-49.18	-29.28	57.62
Price/Sales	-6.27	20.21	21.56
Price/FCF	149.56	-361.60	144.89
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.29	0.54	0.51
Operating Margin	-83.69	0.01	0.08
ROA	69.24	-0.02	0.01
ROE	0.02	-0.03	69.81
ROIC	0.01	< 0.005	-80.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	< 0.005	-440.58
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	466.97	-0.85	-99.82
EPS QOQ	499.00	-2.65	-99.47
FCF QOQ	-0.15	-1.34	-806.73
Revenue QOQ	858.13	-0.09	-99.99
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	211.71	260.87	23.22
Days Sales Outstanding (DSO)	51.12	61.81	20.91
Inventory Turnover	0.43	0.34	-18.84
Debt/Capitalization	0.01	0.01	-2.24
Quick Ratio	6.68	4.63	-30.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.17	11.95	-1.81
Cash	5.45	5.37	-1.39
Capex	-0.16	-0.16	-1.35
Free Cash Flow	0.31	-0.11	-66.05
Revenue	2.08	1.88	-9.60
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	9.52	6.68	-29.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-20.55	-9.98	51.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating